Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    21428760 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the Potential for IV Dosing as an Alternative Route of Administration
Condition: Muscular Dystrophies
Intervention: Drug: Drisapersen
2 Completed Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy
Conditions: Muscular Dystrophy;   Muscular Disease
Intervention:
3 Unknown  Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: Umbilical Cord Mesenchymal Stem Cell

Study has passed its completion date and status has not been verified in more than two years.